| Home | E-Submission | Sitemap | Contact Us |  
logo
The Korean Journal of Medicine 2008;74(4): 411-417.
원저 : 제2형 당뇨병 환자에서 스타틴 치료 시 HDL 콜레스테롤의 변화
박종률, 장혜정, 문정윤, 석지혜, 김미경, 박정현, 이병두
The effect of statins on HDL-cholesterol in type 2 diabetic patients
Jong-Ryul Park, Jang Hye Jung, Jung Youn Moon, Ji-Hye Suk, Mi Kyung Kim, Jeong Hyun Park, Byung Doo Rhee
인제 의대 부산 백병원 호흡기 내과
ABSTRACT
Background/Aims : Statins have been a mainstay of treatment for primary and secondary prevention of coronary heart disease through their beneficial effect on lipid profile. However, their effect on the HDL cholesterol level has been determined to be equivocal or unclear. This study sought to investigate HDL cholesterol response to statin treatment in type 2 diabetic patients. Methods : We retrospectively assessed the effect of statins in 217 patients with type 2 diabetes and dyslipidemia through chart review. Patients who were using medications such as fibrates, niacin, or thiazolidinediones, or had a plasma creatinine concentration greater than 1.5 mg/dL, a fasting triglyceride level greater than 300 mg/dL, or chronic liver disease, were excluded from the study. Result : The mean level of LDL cholesterol was significantly decreased, and the percentage of patients who achieved the normal LDL cholesterol level was increased in this study. The mean HDL cholesterol level after statin treatment was decreased by 2.3%. The percent change of HDL cholesterol was affected by baseline HDL cholesterol level, percent change of total cholesterol, percent change of LDL cholesterol, and baseline total cholesterol level. When subjects were divided into quintiles according to baseline HDL cholesterol, HDL cholesterol level was found to be increased in the lowest two quintiles while it was decreased in the highest two quintiles. Conclusions : There were some patients whose HDL cholesterol level was decreased after statin treatment, depending on their baseline HDL cholesterol level. We think further study on the effect of statins on HDL level will be needed in the future.
Keywords: Statin; HDL cholesterol; Type 2 DM
Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791   Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association of Internal Medicine. All rights reserved.                powerd by m2community